Press Release

Dayton Physicians Commits to Clinical Excellence by Partnering with IntelliDose

Clinical Standards Allow Multi-Specialty Practice to Continually Improve Quality, Efficiency and Efficacy of Cancer Care

WALTHAM, Mass. (Feb 02, 2010) Dayton Physicians LLC, one of Ohio's leading multi-specialty cancer treatment centers, has selected IntrinsiQ's IntelliDose® clinical software to manage complex chemotherapy treatment, safely and efficiently.

Across the country, oncology practices face unprecedented uncertainty with ever-changing reimbursement policies, pressure to integrate with hospital networks and health reform mandates looming. To ensure Dayton Physicians continues to meet the needs of the Greater Dayton community amidst this environment, Dayton Physicians now has a system to consistently improve its quality of patient care and streamline practice procedures and operations.

Dayton Physicians chose IntelliDose, IntrinsiQ's flagship chemotherapy management system, to create consistent clinical treatment pathways across its 12 medical oncologists and reach the highest levels of clinical and operational excellence. Supporting a collaborative practice-wide initiative to confer on the optimal course of care for every diagnosis, Dayton Physicians will use IntelliDose as an information resource to manage every aspect of cancer care: to support physicians' treatment decisions, to administer and track complex chemotherapy regimens, and to capture every charge with rock-solid accuracy.

"Achieving common standards of care amongst the providers within our practice requires an intense commitment – and it would be nearly impossible without an oncology-specific clinical information system," said Dr. Charles L. Bane, president of Dayton Physicians and a hematology and oncology specialist. "With this critical information institutionalized within IntelliDose, we ensure that every patient receives the treatment regimen that all 12 of our oncologists agree is optimal. And we're steps ahead of future expectations that clinical pathways will control cost and quality of care."

Dayton Physicians rigorously evaluated oncology management systems for their ability to manage the unique complexity of chemotherapy, and integrate with its electronic health record (EHR) system of choice, NextGen® EHR from NextGen Healthcare Information Systems, Inc.

"We're pleased to add Dayton Physicians to the growing list of communities that NextGen Healthcare and IntelliDose jointly support," said Larry Erdman, specialty director of oncology at Horsham, Penn.-based NextGen Healthcare. "Integration with IntelliDose helps fulfill our commitment to empowering oncology practices with integrated technology and specialized services that meet their unique clinical and administrative needs."

IntelliDose will provide dramatic operational efficiencies for the practice as well, by accurately capturing charges, drug administrations and waste, inventory records and nursing notes. With a lighter administrative load, physicians and nurses have more time to focus on giving their patients the most time and care possible.

"We admire Dayton Physicians' forward-thinking commitment to achieving high standards of clinical and operational excellence," said Rich Gray, IntelliDose division general manager at IntrinsiQ. "With the installation of IntelliDose, Dayton Physicians staff joins more than 600 oncologists using IntelliDose to treat 20,000-plus patients safely every month."

About IntrinsiQ

IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ's clinical software application, IntelliDose®, captures the treatment decisions and details from more than 600 oncologists, for nearly 20,000 unique patients, creating a database unrivaled in accuracy, detail and timeliness of information about the medical oncology care process. This database is the foundation of products and services that uniquely address the business information needs of pharmaceutical product managers, market researchers and financial analysts. For more information, please visit

IntrinsiQ Company Contact:


IntrinsiQ Media Contact

Kate Greenough
(617) 969-9192